These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7831190)

  • 1. Balance between cortical 5-HT1A and 5-HT2 receptor function: hypothesis for a faster antidepressant action.
    Borsini F
    Pharmacol Res; 1994 Jul; 30(1):1-11. PubMed ID: 7831190
    [No Abstract]   [Full Text] [Related]  

  • 2. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM; Monge A; Del Río J; Lasheras B
    Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between 5-hydroxytryptamine receptor subtypes: is a disturbed receptor balance contributing to the symptomatology of depression in humans?
    Berendsen HH
    Pharmacol Ther; 1995 Apr; 66(1):17-37. PubMed ID: 7630928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin.
    Watanabe Y; Sakai RR; McEwen BS; Mendelson S
    Brain Res; 1993 Jun; 615(1):87-94. PubMed ID: 8364729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of models for spontaneous paroxysmal activity in studies of adaptive changes in serotonin receptors].
    Bobula B; Zahorodna A; Tokarski K; Hess G
    Postepy Hig Med Dosw; 2002; 56(3):377-83. PubMed ID: 12194250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies.
    Gardier AM; Malagié I; Trillat AC; Jacquot C; Artigas F
    Fundam Clin Pharmacol; 1996; 10(1):16-27. PubMed ID: 8900496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.
    Blier P; Bergeron R; de Montigny C
    Neuropsychopharmacology; 1997 May; 16(5):333-8. PubMed ID: 9109104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenoceptors and serotonin receptor function: relevance to antidepressant mechanisms of action.
    Potter WZ
    J Clin Psychiatry; 1996; 57 Suppl 4():4-8. PubMed ID: 8636064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
    Martínez-Esparza J; Oficialdegui AM; Pérez-Silanes S; Heras B; Orús L; Palop JA; Lasheras B; Roca J; Mourelle M; Bosch A; Del Castillo JC; Tordera R; Del Río J; Monge A
    J Med Chem; 2001 Feb; 44(3):418-28. PubMed ID: 11462981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antidepressant activity in 4- and 40-week-old male mice in the forced swimming test: involvement of 5-HT1A and 5-HT1B receptors in old mice.
    David DJ; Bourin M; Hascoët M; Colombel MC; Baker GB; Jolliet P
    Psychopharmacology (Berl); 2001 Feb; 153(4):443-9. PubMed ID: 11243491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of new 3-[(4-aryl)piperazin-1-yl]-1-arylpropane derivatives as potential antidepressants with a dual mode of action: serotonin reuptake inhibition and 5-HT1A receptor antagonism.
    Oficialdegui AM; Martinez J; Pérez S; Heras B; Irurzun M; Palop JA; Tordera R; Lasheras B; del Río J; Monge A
    Farmaco; 2000 May; 55(5):345-53. PubMed ID: 10983279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Developments on Future Antidepressant-related Serotonin Receptors.
    Amidfar M; Kim YK
    Curr Pharm Des; 2018; 24(22):2541-2548. PubMed ID: 30073919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Homozygote mice deficient in serotonin 5-HT1B receptor and antidepressant effect of selective serotonin reuptake inhibitors].
    Trillat AC; Malagié I; Bourin M; Jacquot C; Hen R; Gardier AM
    C R Seances Soc Biol Fil; 1998; 192(6):1139-47. PubMed ID: 10101609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
    Sánchez C; Hyttel J
    Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pharmacological basis of the serotonin system: Application to antidepressant response].
    David DJ; Gardier AM
    Encephale; 2016 Jun; 42(3):255-63. PubMed ID: 27112704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants.
    Martínez J; Pérez S; Oficialdegui AM; Heras B; Orús L; Villanueva H; Palop JA; Roca J; Mourelle M; Bosch A; Del Castillo JC; Lasheras B; Tordera R; del Río J; Monge A
    Eur J Med Chem; 2001 Jan; 36(1):55-61. PubMed ID: 11231049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism.
    Dawson LA; Nguyen HQ; Geiger A
    Neuropharmacology; 1999 Aug; 38(8):1153-63. PubMed ID: 10462128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of activation of the 5-HT1A receptor and adenylate cyclase in the antidepressant-like effect of YL-0919, a dual 5-HT1A agonist and selective serotonin reuptake inhibitor.
    Qin JJ; Chen HX; Zhao N; Yuan L; Zhang YZ; Yang RF; Zhang LM; Li YF
    Neurosci Lett; 2014 Oct; 582():104-8. PubMed ID: 25220701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antidepressant-like activity of novel aralkyl piperazine derivatives targeting SSRI/5-HT
    Gu ZS; Zhou AN; Xiao Y; Zhang QW; Li JQ
    Eur J Med Chem; 2018 Jan; 144():701-715. PubMed ID: 29291438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.